Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis

Rheumatology International

Volumn 30, Issue 2, 2009, Pages 193-198

  Ferrante, A ^a   Giardina, A R ^a   Ciccia, F ^a   Parrinello, G ^a   Licata, G ^a   Avellone, G ^a   Giardina, E ^a   Impastato, R ^a   Triolo, Giovanni ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Atherosclerosis; DMARDs; Rheumatoid arthritis; TNF

Indexed keywords

ADALIMUMAB; ETANERCEPT; FOLIC ACID; INFLIXIMAB; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADD ON THERAPY; ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CAROTID ARTERY DISEASES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA; TUNICA MEDIA;

EID: 71349086382     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0935-2     Document Type: Article

References (30)

1. C Gonzalez-Juanatey J Llorca A Testa J Revuelta C Garcia-Porrua MA Gonzalez-Gay 2003 Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinical evident atherosclerotic disease Medicine (Baltimore) 82 407 413 10.1097/01.md.0000101572.76273.60 10.1097/01.md.0000101572.76273.60 (Pubitemid 37445043)
2. DH Solomon EW Karlson EB Rimm CC Cannuscio LA Mandl JE Manson, et al. 2003 Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 107 1303 1307 10.1161/01.CIR.0000054612.26458.B2 10.1161/01.CIR.0000054612.26458.B2 12628952 (Pubitemid 36314415)
3. LM Fischer RG Schlienger C Matter H Jick CR Meier 2004 Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction Am J Cardiol 93 198 200 10.1016/j.amjcard.2003.09. 037 10.1016/j.amjcard.2003.09.037 14715346 (Pubitemid 38058729)
4. I del Rincòn K Williams MP Stern GL Freeman A Escalante 2001 High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional risk factors Arthritis Rheum 44 2737 2745 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-# 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-# 11762933 (Pubitemid 34016192)
5. S Van Doornum G McColl IP Wicks 2002 Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46 862 873 10.1002/art.10089 10.1002/art.10089 11953961 (Pubitemid 34303796)
6. S Hansel G Lassig F Pistrach J Passauer 2003 Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity Artherosclerosis 170 177 180 10.1016/S0021-9150(03)00281-8 10.1016/S0021- 9150(03)00281-8 1:CAS:528:DC%2BD3sXmvVyhsrg%3D (Pubitemid 37083577)
7. G Vaudo S Marchesi R Gerli R Allegrucci A Giordano D Siepi, et al. 2004 Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity Ann Rheum Dis 63 31 35 10.1136/ard.2003.007740 10.1136/ard.2003.007740 1:STN:280:DC%2BD2c%2FhtV2jtA%3D%3D 14672888 (Pubitemid 38064600)
8. N Sattar DW Mc Carey H Capell IB McInnes 2003 Explaining how high grade systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2957 2963 10.1161/01.CIR.0000099844.31524.05 10.1161/01.CIR.0000099844.31524.05 14676136 (Pubitemid 37553561)
9. D Hurlimann A Forster G Noll F Enseleit R Chenevard O Distler, et al. 2002 Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis Circulation 106 2184 2187 10.1161/01.CIR.0000037521.71373.44 10.1161/01.CIR.0000037521.71373.44 12390945 (Pubitemid 35222210)
10. C Gonzalez-Juanatey A Testa A Garcia-Castelo C Garcia-Porrua J Llorca MA Gonzalez-Gay 2004 Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor-antibody Arthritis Rheum 51 447 450 10.1002/art.20407 10.1002/art.20407 1:CAS:528:DC%2BD2cXls1Sjtr0%3D 15188332
11. Maki-Petaja KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW et al (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 114(11):1185-1192. doi: 10.1161/CIRCULATIONAHA.105.601641 (Pubitemid 44386483)
12. S Van Doornum G McColl IP Wicks 2005 Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis Rheumatology (Oxford) 44 1428 1432 10.1093/rheumatology/kei033 10.1093/rheumatology/kei033 (Pubitemid 41631868)
13. C Irace G Mancuso E Fiaschi, et al. 2004 Effect of anti TNF alpha therapy on arterial diameter and wall shear stress and HDL cholesterol Atherosclerosis 177 113 118 10.1016/j.atherosclerosis.2004.04.031 10.1016/j.atherosclerosis. 2004.04.031 1:CAS:528:DC%2BD2cXos1ektLg%3D 15488873 (Pubitemid 39361145)
14. VP van Halm MT Nurmohamed JW Twisk BA Dijkmans AE Voskuyl 2006 Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study Arthritis Res Ther 8 5 R151 10.1186/ar2045 10.1186/ar2045 16984661
15. C Gonzalez-Juanatey J Llorca C Garcia-Porrua J Martin MA Gonzalez-Gay 2006 Effect of anti-tumor necrosis factor a therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis Arthritis Rheum 55 150 153 10.1002/art.21707 10.1002/art.21707 1:CAS:528:DC%2BD28XitFWht74%3D 16463428 (Pubitemid 43235141)
16. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 10.1002/art.1780310302 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 3358796
17. ML Prevoo MA van't Hof HH Kuper MA van Leeuwen LB van de Putte PL van Riel 1995 Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44 48 10.1002/art. 1780380107 10.1002/art.1780380107 1:STN:280:DyaK2M7hvVeqtA%3D%3D 7818570
18. JF Fries P Spitz RG Kraines HR Holman 1980 Measurement of patients outcome in arthritis Arthritis Rheum 23 137 145 10.1002/art.1780230202 10.1002/art.1780230202 1:STN:280:DyaL3c7ltlGlsQ%3D%3D 7362664 (Pubitemid 10164318)
19. WT Friedwal RI Levy DS Friedckson 1972 Estimation of the concentration of low density lipoprotein in plasma, without use of preparative ultracentrifuge Clin Chem 18 499 502
20. S Van Doornum G McColl A Jenkins DJ Green, et al. 2003 Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function Arthritis Rheum 48 72 80 10.1002/art.10735 10.1002/art.10735 12528106 (Pubitemid 36091650)
21. KM Mäki-Petäjä FC Hall AD Booth SML Wallace, et al. 2006 Rheumatoid arthritis is associated with increased aortic pulse wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy Circulation 114 1185 1192 10.1161/CIRCULATIONAHA.105.601641 10.1161/CIRCULATIONAHA.105.601641 16952987 (Pubitemid 44386483)
22. YB Park SK Lee WK Lee CH Suh, et al. 1999 Lipid profiles in untreated patients with rheumatoid arthritis J Rheumatol 26 1701 1704 1:STN:280: DyaK1MznvVaktg%3D%3D 10451065
23. C Grunfeld KR Feingold 1991 Tumour necrosis factor, cytokines and the hyperlipidemia of infection Trends Endocrinol Metab 2 213 219 10.1016/1043-2760(91)90027-K 10.1016/1043-2760(91)90027-K 1:CAS:528: DyaK38XktVGmtr4%3D 18411185
24. E Spanakis P Sidiropoulos J Papadakis E Ganotakis, et al. 2006 Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab J Rheumatol 33 2440 2446 1:CAS:528:DC%2BD2sXhtVCnur0%3D 17014005
25. G Geroulakos DJ O'Gorman E Kalodiki DJ Sheridan AN Nicolaides 1994 The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease Eur Heart J 15 781 785 1:STN:280:DyaK2cznsVensg%3D%3D 8088266
26. R Tang M Hennig B Thomasson R Scherz, et al. 2000 Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA) J Hypertens 18 197 201 10.1097/00004872-200018020-00010 10.1097/00004872-200018020-00010 1:CAS:528:DC%2BD3cXhsFahsLc%3D 10694188
27. JT Salonen R Salonen 1993 Ultrasound B-mode imaging in observational studies of atherosclerotic progression Circulation 87 II56 II65 1:STN:280:DyaK3s7osFantw%3D%3D 8443925
28. ML Bots MA Evans WA Riley DE Grobbee 2003 Carotid intima-media thickness measurements in intervention studies Stroke 34 2985 2994 10.1161/01.STR. 0000102044.27905.B5 10.1161/01.STR.0000102044.27905.B5 14615619 (Pubitemid 37517782)
29. DE Grobbee ML Bots 1994 Carotid artery intima-media thickness as an indicator of generalized atherosclerosis J Intern Med 236 567 573 10.1111/j.1365-2796.1994.tb00847.x 1:STN:280:DyaK2M%2FltlKkuw%3D%3D 7964435
30. I Del Rincon DH O'leary GL Freeman A Escalante 2007 Acceleration of atherosclerosis during the course of rheumatoid arthritis Atherosclerosis 195 354 360 10.1016/j.atherosclerosis.2006.09.027 10.1016/j.atherosclerosis.2006.09. 027 1:CAS:528:DC%2BD2sXhtlahtb%2FF 17097659 (Pubitemid 350087940)